“Clinical AI is developing faster than the framework to regulate it,” AEI senior fellow
@ScottGottliebMD writes in a new op-ed. Drawing lessons from how lab-developed tests (LDTs) were regulated, he urges Congress to build a framework that balances local innovation with wider access.